Institutional Cluster

ZNTL

Zentalis Pharmaceuticals, Inc.
MIXED
Impact 4/10
Horizonweeks Processed3mo ago
Institutional cluster: 3 buyers, 2 sellers (mixed)
Actionable Insight ◆ Mixed

The divergence between D.E. Shaw (accumulating) and Citadel (reducing) signals high uncertainty around ZNTL's pipeline milestones. With 60% analyst bullishness but 13F lag, traders should watch for upcoming clinical data readouts as the next catalyst to resolve the directional debate.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
ZNTL ▲ +7.47% at T+60d
NEUTRAL call ✓ call won +7.47% · α vs SPY +4.20% · entry $3.75 → $4.03
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
+0.80%
call +0.80% · α -0.96%
$3.78
settled 4mo ago
T+5d
-1.33%
call -1.33% · α -2.01%
$3.70
settled 4mo ago
T+20d
+30.13%
call +30.13% · α +28.35%
$4.88
settled 3mo ago
T+60d
+7.47%
call +7.47% · α +4.20%
$4.03
settled 24d ago

Executive Summary

Institutional cluster for ZNTL in Q3 2024 reveals a mixed picture: D.E. Shaw doubled its position to $4.2M and Balyasny added, while Citadel trimmed 40% of its large $18.4M stake and Legal & General nearly exited. Net outflow of ~$5.2M from tracked institutions, but the active manager buying (D.E. Shaw, Balyasny) suggests some conviction ahead of upcoming catalysts.

Key Financial Metrics

Direction
distributing
Buy Value
$4.6M
Sell Value
$18.6M
Net Flow
-$5.2M

Institutional Positions

Net institutional flow: -$5.2M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
D.E. ShawDOUBLED+369.6%$4.2M$3.2M
Voya Investment ManagementDOUBLED+159.6%$184.0K$105.0K
Balyasny Asset ManagementADD+70.8%$253.0K$88.0K

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
CitadelTRIM-39.6%$18.4M-$8.4M
Legal & General GroupNEAR_EXIT-90.7%$218.0K-$199.9K

Key Facts

  • 3 institutions accumulated $4.6M (net +$3.4M) while 2 institutions sold $8.6M net
  • D.E. Shaw (quant) DOUBLED its stake to 1.13M shares worth $4.2M, a $3.2M increase
  • Citadel (quant) trimmed 39.6% of its position, selling ~1.79M shares worth $8.4M
  • Balyasny Asset Management added 70.8% to its position, now 68.7K shares
  • Legal & General Group (passive) nearly fully exited, reducing from $218K to $18K
  • Net dollar flow: sellers outsize buyers $8.6M to $3.4M

Financial Impact

Net institutional outflow of ~$5.2M, driven by Citadel's $8.4M reduction partially offset by D.E. Shaw's $3.2M accumulation

institutional ownershipfloat turnover

Risk Factors

  • 13F data reflects quarter-end positions with a 45-day lag; cluster may have been unwound
  • Clinical-stage biotech binary risk from pipeline failures
  • Historical long calls on ZNTL have underperformed at T+20 (20% win rate)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ZNTL-2024-Q3
13 reports for ZNTL
Performance horizon
56% Hit rate 5 of 9 directional calls best @ T+1▲ +49.55%Apr 9, 2026
Filters
Rows
Reports for ZNTL — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
8-K
BEARISH ★ 6/10
$3.71 $3.13▲ +15.52%▲ +13.54%—
Aug 14, 2026
7w ago
Press Release
BEARISH ★ 6/10
$3.56 $3.50▲ +1.69%▼ −0.31%—
Jun 11, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$3.75 $4.88▲ +30.13%▲ +28.35%—
Jun 1, 2026
17w ago
Press Release
NEUTRAL ★ 2/10
$3.95 $4.36▲ +10.25%▲ +11.82%—
May 21, 2026
19w ago
Press Release
BULLISH ★ 6/10
$4.06 $3.70▼ −8.87%▼ −7.45%—
May 21, 2026
19w ago
8-K
BULLISH ★ 6/10
$4.06 $3.70▼ −8.87%▼ −7.45%—
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$4.28 $3.52▼ −17.76%▼ −17.14%—
May 12, 2026
20w ago
Press Release
BULLISH ★ 7/10
$4.28 $3.52▼ −17.76%▼ −17.14%—
Apr 21, 2026
23w ago
Press Release
NEUTRAL ★ 4/10
$3.99 $3.63▼ −9.02%▼ −13.94%—
Apr 17, 2026
24w ago
Press Release
BULLISH ★ 7/10
$4.64 $4.09▼ −11.85%▼ −17.22%—
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (64h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026